Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and PK of Devil's Claw in Knee Osteoarthritis
NCT03641248Phase 1Withdrawn
- Sponsor
- University of Missouri
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Allya in osteoarthritis (OA), sponsored by University of Missouri. Planned start May 2021; status: withdrawn.
02
Drugs
Allya
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03641248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03641248.